NOVONIX Ltd current report, Q3 FY2026

Business Context and Reporting Period

Company: NOVONIX Ltd
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: September 2026
Date of Filing: September 21, 2026
Principal Executive Office: Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 6-K serves as a notification of a corporate action rather than a financial results report.

Material Changes

The primary material event disclosed is the cessation of securities, as detailed in the attached Exhibit 99.1 (Appendix 3H) dated September 18, 2026.

Guidance, Outlook, and Risks

The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the notification of the cessation of securities.

Investor Verification Checklist

  • Verify the specific details of the "cessation of securities" referenced in Exhibit 99.1 (Appendix 3H).
  • Confirm the impact of this cessation on the company's capital structure and outstanding share count.
  • Review the original regulatory filing (Appendix 3H) for the effective date and scope of the cessation.